Skip to main content

Posts

Showing posts from November, 2019

Omicorn medicine found : All Details

  Omicorn medicine found : All Details   As the world worries that the omicron coronavirus variant may cause a surge of cases and weaken vaccines, drug developers have some encouraging news: Two new COVID-19 pills are coming soon, and are expected to work against all versions of the virus. Omicorn medicine found : All Details   Omicorn medicine found : All Details The Food and Drug Administration is expected to soon authorize a pill made by Merck and Ridgeback Biotherapeutics, called molnupiravir, which reduces the risk of hospitalization and death from COVID-19 by 30% if taken within five days of the onset of symptoms.   Another antiviral pill, developed by Pfizer, may perform even better. An interim analysis showed that the drug was 85% effective when taken within five days of the start of symptoms. The FDA could authorize it by year’s end.   Since the start of the pandemic, scientists have hoped for convenient options like these: pills that could be prescribed by